Female, n (%) | Age in years, mean (SD) | Smokers, n (%) | Comorbiditya, n (%) | >2 Oral drugs, n (%) | >2 Oral cardiovascular drugs, n (%) | Cardiovascular disease in family, n (%) | |
---|---|---|---|---|---|---|---|
High risk (n = 217) | 105 (48.4) | 64.5 (7.3) | 55 (25.5) | 113 (32.8) | 142 (65.4) | 32 (14.7) | 123 (56.7) |
Low risk (n = 345) | 214 (62.0) | 54.5 (8.5) | 53 (15.4) | 84 (38.7) | 196 (56.8) | 25 (7.2) | 139 (40.3) |
Advice to continue medication (n = 201) | 122 (60.7) | 55.4 (9.0) | 38 (18.9) | 74 (36.8) | 112 (55.7) | 14 (7.0) | 81 (40.3) |
Advice to stop medication (n = 144) | 92 (63.9) | 53.2 (7.7) | 15 (10.4) | 39 (27.1) | 84 (58.3) | 11 (7.6) | 58 (40.3) |
Still stopped after 6 months (n = 80) | 50 (62.5) | 51.8 (7.0) | 6 (7.5) | 23 (28.8) | 21 (26.3) | 1 (1.3) | 33 (41.3) |
Restarted within 6 months (n = 55) | 36 (65.5) | 53.9 (7.9) | 8 (14.5) | 13 (23.6) | 16 (29.1) | 7 (12.7) | 23 (41.8) |
Not stopped (n = 9) | 6 (66.7) | 58.7 (7.6) | 1 (11.1) | 3 (33.3) | 4 (44.4) | 3 (33.3) | 2 (22.2) |
SD = standard deviation.
↵a Asthma/chronic obstructive pulmonary disease (COPD), digestive, urogenital, psychosomatic, and/or musculoskeletal problems.